Baxter International Inc. (BAX): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Baxter International ( BAX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole was unchanged today. By the end of trading, Baxter International rose $1.53 (2.3%) to $68.39 on average volume. Throughout the day, 4,059,424 shares of Baxter International exchanged hands as compared to its average daily volume of 3,070,200 shares. The stock ranged in a price between $66.96-$68.42 after having opened the day at $67.02 as compared to the previous trading day's close of $66.86. Other companies within the Health Services industry that increased today were: BG Medicine ( BGMD), up 22.4%, Bovie Medical Corporation ( BVX), up 15.0%, Spherix ( SPEX), up 10.9% and Escalon Medical Corporation ( ESMC), up 8.8%.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $36.8 billion and is part of the health care sector. Shares are down 3.9% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, IsoRay ( ISR), down 13.1%, Response Genetics ( RGDX), down 9.4%, Foundation Medicine ( FMI), down 8.1% and Oculus Innovative ( OCLS), down 6.8% , were all laggards within the health services industry with Thermo Fisher Scientific ( TMO) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

These Stocks Are Ready to Reverse Course

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways